Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use

PURPOSE: Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity of cancer treatment, with potential to significantly impact cancer survivors’ long-term quality of life. Patient reported outcome measures (PROMs) are increasingly utilised to evaluate CIPN. However, guidance remains lac...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tiffany, Park, Susanna B., Battaglini, Eva, King, Madeleine T., Kiernan, Matthew C., Goldstein, David, Rutherford, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546984/
https://www.ncbi.nlm.nih.gov/pubmed/35596913
http://dx.doi.org/10.1007/s11136-022-03154-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546984/
https://www.ncbi.nlm.nih.gov/pubmed/35596913
http://dx.doi.org/10.1007/s11136-022-03154-7

Ejemplares similares